Pavion Blue Capital, LLC Bristol Myers Squibb CO Transaction History
Pavion Blue Capital, LLC
- $201 Million
- Q2 2024
A detailed history of Pavion Blue Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pavion Blue Capital, LLC holds 14,233 shares of BMY stock, worth $693,147. This represents 0.29% of its overall portfolio holdings.
Number of Shares
14,233
Previous 14,233
-0.0%
Holding current value
$693,147
Previous $771,000
23.35%
% of portfolio
0.29%
Previous 0.38%
Shares
9 transactions
Others Institutions Holding BMY
# of Institutions
2,399Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.09 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.73 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.45 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.63 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$2.88 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $104B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...